Skip to content

Study · Not a test of the peptide alone · 2016

2 results

Stage IV Wilms Tumor Treated by Korean Medicine, Hyperthermia and Thymosin-α1: A Case Report.

Lee D, Kim SS, Seong S, Cho W, Yu H

Case reports in oncology1 Jan 2016Cited by 3 (Europe PMC)

PMID27293398 (opens in a new tab)PMCIDPMC4899649 (opens in a new tab)DOI10.1159/000443724 (opens in a new tab)PepBankPUB-27293398
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01HumanNot a test of Thymosin alpha-1 aloneCase report or seriesEfficacy outcome

    In a female patient with stage IV Wilms tumor, a regimen of herbal remedy, hyperthermia and thymosin alpha‑1 was followed by no visible liver metastasis on CT.

    In plain wordsIn one patient with Wilms tumor, a combined treatment with herbal medicine, heat therapy and thymosin alpha‑1 was followed by no visible liver metastasis.

    Peptide
    Thymosin alpha-1
    Outcome
    DecreaseLiver metastasis on CT
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    According to the CT result on July 15th, 2015, the liver metastasis was not seen anymore
    2 context sentences
    Summary · context
    The integrative medical therapy was done with hyperthermia therapy (oncothermia) and 1.6 mg of thymosin-α1 treatment (Zadaxin) i.m.
    Summary · context
    Our patient, a female Korean mongoloid outpatient, was treated from October 25, 2014, to July 22, 2015.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

  2. 02HumanNot a test of Thymosin alpha-1 aloneCase report or seriesEfficacy outcome

    In one patient with stage IV Wilms tumor, the lung metastasis stayed stable without progression during a regimen of herbal remedy, hyperthermia and thymosin alpha‑1.

    In plain wordsIn one patient with Wilms tumor, the lung metastasis stayed stable during a combined treatment that included thymosin alpha‑1.

    Peptide
    Thymosin alpha-1
    Outcome
    No significant changeLung metastasis on CT
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    while the lung metastasis was maintained stably without tumor progress.
    2 context sentences
    Summary · context
    The integrative medical therapy was done with hyperthermia therapy (oncothermia) and 1.6 mg of thymosin-α1 treatment (Zadaxin) i.m.
    Summary · context
    Our patient, a female Korean mongoloid outpatient, was treated from October 25, 2014, to July 22, 2015.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.